Truist Financial Forecasts Strong Price Appreciation for Pediatrix Medical Group (NYSE:MD) Stock

Pediatrix Medical Group (NYSE:MD - Free Report) had its price objective raised by Truist Financial from $15.00 to $18.00 in a report published on Friday morning,Benzinga reports. Truist Financial currently has a hold rating on the stock.

MD has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Macquarie initiated coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price for the company. UBS Group upped their price target on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a research note on Tuesday, November 5th. Jefferies Financial Group lifted their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Finally, Mizuho increased their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Trading Down 1.9 %

MD traded down $0.31 during trading hours on Friday, reaching $15.38. The company's stock had a trading volume of 915,898 shares, compared to its average volume of 572,436. The stock has a market cap of $1.32 billion, a PE ratio of -12.81, a P/E/G ratio of 1.74 and a beta of 1.57. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The business's 50-day moving average is $13.92 and its 200-day moving average is $13.05.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, equities research analysts predict that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Hedge funds have recently modified their holdings of the stock. Nomura Asset Management Co. Ltd. increased its holdings in Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the period. Quest Partners LLC grew its position in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after buying an additional 622 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after buying an additional 1,040 shares during the period. Quarry LP raised its holdings in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Finally, AlphaQuest LLC raised its holdings in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.